RecruitingOBSERVATIONAL

Impact of a Multidisciplinary Consultation Program on Drug Adherence in First Oral Anticancer Treatment

This study explores how a team of healthcare professionals can better support people starting new oral cancer medicines. These oral treatments are a big change, offering different benefits but also different side effects than traditional treatments. Sometimes, it's hard for patients to take their medicine exactly as prescribed because of side effects, complicated schedules, or special instructions. Not taking medicine correctly can make it less effective and might even lead to more hospital visits. The study wants to see if this 'multidisciplinary consultation program' helps patients take their oral cancer medicines more regularly and whether this support makes a difference to their overall care and well-being, by looking at how well they take their medication before and after the program.

At a glance

Status

Recruiting

Sponsor

Centre Hospitalier Universitaire, Amiens

Enrolment target

300

Start

11 Mar 2021

Estimated completion

01 Mar 2026

Multidisciplinary Consultation Program Adherence to Oral Anticancer Treatment Drug Related Toxicity Securing Medication Management

What is this study about?

In recent years, cancer treatment has seen big changes, with many new cancer drugs now available as tablets or capsules, rather than injections or drips. This is great for many people, as it can mean fewer hospital visits. However, taking medication at home comes with its own set of challenges. These oral medicines can have different side effects than older treatments, and sometimes the instructions for taking them can be quite complicated.

It's very important to take these medicines exactly as prescribed to get the best results. But we know that it can be hard for various reasons. For example, some people might experience difficult side effects, forget to take doses, or find the schedule confusing. Sometimes, just getting hold of these special medications can be tricky. When people don't take their medicine as directed, it might not work as well, and there's a chance they could end up needing more hospital care, which also costs the healthcare system more.

This study wants to find out if a special support program can make a real difference. This program involves a team of different healthcare experts, like pharmacists, nurses, and doctors, working together to help people manage their oral cancer treatments. The main goal is to see if, with this extra support, people are better at taking their medication regularly and correctly. They will compare how well people take their medicine before they start this support program and after it's put in place.

Key takeaways

The study aims to improve how well people take their oral cancer medicines.
It involves support from a team of healthcare experts to help manage treatment.
The goal is better treatment effectiveness and fewer problems or hospital visits.
Participation includes receiving guidance on managing your existing oral cancer drugs.
The support program is designed to help with potential challenges of oral medications.

Who may be eligible?

To be part of this study, you need to be an adult, aged 18 or older. You must also have recently been diagnosed with cancer or have had cancer come back, and be about to start taking a new oral (tablet or capsule) cancer treatment.

It's also important that you can speak French, as the study materials and interactions will be in French.

However, you cannot join the study if you are only taking hormone therapy for your cancer, if you have severe mental health conditions, or if you do not speak French.

Could this study suit you?

Answer these quick questions to see if you may be eligible. This is a guide only — the research team makes the final call.

Are you 18 years old or older?
Have you recently been diagnosed with cancer or had it return?
Are you about to start a new oral (tablet/capsule) cancer treatment?
Can you speak French comfortably?
Are you NOT just taking hormone therapy?
Do you NOT have severe mental health conditions?

Answer every question to see your result.

What does participation involve?

If you decide to take part in this study, you would primarily be involved in a 'multidisciplinary consultation program'. This means you would meet and receive support from a team of different healthcare professionals, such as doctors, nurses, and pharmacists, who will work together to help you manage your oral cancer medication. The study will look at how well you take your medication before you start this program and after you've been part of it for a while. There aren't many details given about how many visits you would have or the exact duration, but the focus is on providing support and then checking if that support helps you take your medication correctly over time. You would continue to receive your prescribed oral cancer treatment as normal.

Potential risks and benefits

Taking part in this study offers the potential benefit of receiving extra support and guidance from a team of healthcare professionals to help you manage your oral cancer treatment, which might improve how well you take your medication and reduce potential side effects. There are no direct medical risks from participating, as the study focuses on providing support rather than testing a new drug. The main commitment would be attending appointments with the consultation team. Remember, you can choose to withdraw from the study at any time, for any reason, without it affecting your usual medical care.

Locations (1)

CHU Amiens
Verified postcode
Amiens, France· Recruiting

Common questions

What kind of cancer treatments does this study focus on?

This study is specifically for people who are starting new oral cancer treatments, which means medications taken by mouth as tablets or capsules.

What is a 'multidisciplinary consultation program'?

It's a support program where a team of different healthcare experts (like doctors, nurses, and pharmacists) works together to help you manage your oral cancer medication and any issues you might have.

Why is it important to take my medication correctly?

Taking your anti-cancer medication exactly as prescribed helps it work best against your cancer and can reduce the chance of side effects or needing extra hospital care.

Will I have to take different medicines if I join this study?

No, you will continue to take your prescribed oral cancer treatment. The study is about providing support for taking that medication, not changing it.

What does 'medication possession ratio' mean?

In simple terms, it's a way to measure how consistently someone is taking their medication by looking at how often they refill their prescriptions compared to how often they should be taking them.

How to find out more

Aurélie terrier-lenglet, DR

terrier-lenglet.aurelie@chu-amiens.fr 0322087173 Official trial record

Always speak to your GP or specialist before deciding to take part in a study.